School of Pharmacy, Nanjing Medical University, Nanjing 211166, China.
Department of Pharmacy, The Second Affiliated Hospital of Nantong University, China.
J Pharm Biomed Anal. 2018 May 30;154:180-190. doi: 10.1016/j.jpba.2018.03.003. Epub 2018 Mar 3.
In this work, surface magnetic molecularly imprinted polymers (SMMIPs) were synthesized and used as artificial receptors in the dispersive magnetic solid phase extraction (DMSPE) for capturing potential neuronal nitric oxide synthase-post synaptic density protein-95 (nNOS-PSD-95) uncouplers, which is known as neuroprotection against stroke. Factors that affected selective separation and adsorption of the artificial receptors, such as the amount of template, the types of functional monomer and porogen solvents, and the molar ratio of template/functional monomer/cross-linker were optimized. The artificial receptors were also characterized using fourier transformed infrared, scanning electron microscope, thermal gravimetric analysis and physical property measurement systems. Multiple interactions between template and SMMIPs led to larger binding capacities, faster binding kinetics, quicker separation abilities and more efficient selectivity than the surface magnetic nonimprinted polymers (SMNIPs). The SMMIPs were successfully applied to capture potential nNOS-PSD-95 uncouplers from complex samples, and eight compounds were seized and confirmed rapidly when combined with HPLC and MS. The detection of the new nNOS-PSD-95 uncouplers ranged from 0.001 to 1.500 mg/mL with correlation coefficients of 0.9990-0.9995. The LOD and LOQ were 0.10-0.68 μg/mL and 0.47-2.11 μg/mL, respectively. The neuroprotective effect and co-immunoprecipitation test in vitro revealed that Emodin-1-O-β-d-glucoside, Rhaponticin, Gnetol and 2,3,5,4'-Tetrahydroxystilbene-2-O-β-d-glucoside have neuroprotective and uncoupling activities, and that they may be the new uncouplers of nNOS-PSD-95.
在这项工作中,合成了表面磁性分子印迹聚合物(SMMIPs),并将其用作分散固相萃取(DMSPE)中的人工受体,用于捕获潜在的神经元一氧化氮合酶-突触后密度蛋白-95(nNOS-PSD-95)解偶联剂,这是一种已知的脑卒中神经保护剂。优化了影响人工受体选择性分离和吸附的因素,如模板量、功能单体和致孔剂溶剂的类型,以及模板/功能单体/交联剂的摩尔比。还使用傅里叶变换红外光谱、扫描电子显微镜、热重分析和物性测量系统对人工受体进行了表征。模板与 SMMIPs 之间的多种相互作用导致其具有更大的结合容量、更快的结合动力学、更快的分离能力和更高的选择性,优于表面磁性非印迹聚合物(SMNIPs)。SMMIPs 成功地应用于从复杂样品中捕获潜在的 nNOS-PSD-95 解偶联剂,与 HPLC 和 MS 结合后可快速捕获和确认 8 种化合物。新的 nNOS-PSD-95 解偶联剂的检测范围为 0.001-1.500mg/mL,相关系数为 0.9990-0.9995。LOD 和 LOQ 分别为 0.10-0.68μg/mL 和 0.47-2.11μg/mL。体外神经保护作用和共免疫沉淀试验表明,大黄素-1-O-β-d-葡萄糖苷、瑞马酮、淫羊藿苷和 2,3,5,4'-四羟基二苯乙烯-2-O-β-d-葡萄糖苷具有神经保护和解偶联活性,它们可能是 nNOS-PSD-95 的新解偶联剂。